These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35876317)

  • 1. Systematic Review and Meta-Analysis of the Placebo Effect and its Correlates in Obsessive Compulsive Disorder.
    Mohamadi S; Ahmadzad-Asl M; Nejadghaderi SA; Jabbarinejad R; Mirbehbahani SH; Sinyor M; Richter MA; Davoudi F
    Can J Psychiatry; 2023 Jul; 68(7):479-494. PubMed ID: 35876317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unguided Computer-Assisted Self-Help Interventions Without Human Contact in Patients With Obsessive-Compulsive Disorder: Systematic Review and Meta-analysis.
    Imai H; Tajika A; Narita H; Yoshinaga N; Kimura K; Nakamura H; Takeshima N; Hayasaka Y; Ogawa Y; Furukawa T
    J Med Internet Res; 2022 Apr; 24(4):e35940. PubMed ID: 35451993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD).
    Elliott SJ; Marshall D; Morley K; Uphoff E; Kumar M; Meader N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013173. PubMed ID: 34693989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: A meta-analysis.
    Sugarman MA; Kirsch I; Huppert JD
    J Affect Disord; 2017 Aug; 218():217-226. PubMed ID: 28477500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-Analysis: Pediatric Placebo Response in Depression Trials Does Not Replicate in Anxiety and Obsessive-Compulsive Disorder Trials.
    Nasir M; Li F; Courley S; Olten B; Bloch MH
    J Child Adolesc Psychopharmacol; 2021 Dec; 31(10):670-684. PubMed ID: 34558984
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of Repetitive Transcranial Magnetic Stimulation on Comorbid Anxiety and Depression Symptoms in Obsessive-Compulsive Disorder: A Meta-Analysis of Randomized Sham-Controlled Trials.
    Thatikonda NS; Vinod P; Balachander S; Bhaskarpillai B; Arumugham SS; Reddy YCJ
    Can J Psychiatry; 2023 Jun; 68(6):407-417. PubMed ID: 35989677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
    JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.
    Costa DLC; Diniz JB; Requena G; Joaquim MA; Pittenger C; Bloch MH; Miguel EC; Shavitt RG
    J Clin Psychiatry; 2017 Jul; 78(7):e766-e773. PubMed ID: 28617566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect.
    Overbeek T; Schruers K; Vermetten E; Griez E
    J Clin Psychiatry; 2002 Dec; 63(12):1106-12. PubMed ID: 12523869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis of the placebo effect in panic disorder: Implications for research and clinical practice.
    Ahmadzad-Asl M; Davoudi F; Mohamadi S; Hadi F; Nejadghaderi SA; Mirbehbahani SH; Jabbarinejad R; Saneh S; Arshadi M; Naserbakht M; Sinyor M; Kabir A; Shamshiri A
    Aust N Z J Psychiatry; 2022 Sep; 56(9):1130-1141. PubMed ID: 34996304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
    Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
    PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of obsessive-compulsive disorders (OCD) symptoms among health care workers in COVID-19 pandemic: a systematic review and meta-analysis.
    SoleimanvandiAzar N; Amirkafi A; Shalbafan M; Ahmadi SAY; Asadzandi S; Shakeri S; Saeidi M; Panahi R; Nojomi M
    BMC Psychiatry; 2023 Nov; 23(1):862. PubMed ID: 37990311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamatergic Agents as Add-On Medication for the Treatment of Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis.
    Laoutidis ZG; Lekka GE; Kioulos KT
    J Clin Psychiatry; 2016 Dec; 77(12):e1576-e1583. PubMed ID: 27780337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between obsessive compulsive disorder and obsessive compulsive personality disorder: prevalence and clinical presentation.
    Gordon OM; Salkovskis PM; Oldfield VB; Carter N
    Br J Clin Psychol; 2013 Sep; 52(3):300-15. PubMed ID: 23865406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual dysfunction and satisfaction in obsessive compulsive disorder: protocol for a systematic review and meta-analysis.
    Pozza A; Veale D; Marazziti D; Delgadillo J; Albert U; Grassi G; Prestia D; Dèttore D
    Syst Rev; 2020 Jan; 9(1):8. PubMed ID: 31918750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of study characteristics, methodological rigour and publication bias on efficacy of pharmacotherapy in obsessive-compulsive disorder: a systematic review and meta-analysis of randomised, placebo-controlled trials.
    Cohen SE; Zantvoord JB; Storosum BWC; Mattila TK; Daams J; Wezenberg B; de Boer A; Denys DAJP
    BMJ Ment Health; 2024 Feb; 27(1):. PubMed ID: 38350669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
    JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis: Memantine augmentation in moderate to severe obsessive-compulsive disorder.
    Modarresi A; Chaibakhsh S; Koulaeinejad N; Koupaei SR
    Psychiatry Res; 2019 Dec; 282():112602. PubMed ID: 31630042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.